...
首页> 外文期刊>Biotechnology and Bioengineering >Downscaling screening cultures in a multifunctional bioreactor array-on-a-chip for speeding up optimization of yeast-based lactic acid bioproduction
【24h】

Downscaling screening cultures in a multifunctional bioreactor array-on-a-chip for speeding up optimization of yeast-based lactic acid bioproduction

机译:多功能生物反应器阵列缩小筛选培养物,用于加速酵母基乳酸生效的优化

获取原文
获取原文并翻译 | 示例
           

摘要

A key challenge for bioprocess engineering is the identification of the optimum process conditions for the production of biochemical and biopharmaceutical compounds using prokaryotic as well as eukaryotic cell factories. Shake flasks and bench-scale bioreactor systems are still the golden standard in the early stage of bioprocess development, though they are known to be expensive, time-consuming, and labor-intensive as well as lacking the throughput for efficient production optimizations. To bridge the technological gap between bioprocess optimization and upscaling, we have developed a microfluidic bioreactor array to reduce time and costs, and to increase throughput compared with traditional lab-scale culture strategies. We present a multifunctional microfluidic device containing 12 individual bioreactors (V-t = 15 mu l) in a 26 mm x 76 mm area with in-line biosensing of dissolved oxygen and biomass concentration. Following initial device characterization, the bioreactor lab-on-a-chip was used in a proof-of-principle study to identify the most productive cell line for lactic acid production out of two engineered yeast strains, evaluating whether it could reduce the time needed for collecting meaningful data compared with shake flasks cultures. Results of the study showed significant difference in the strains' productivity within 3 hr of operation exhibiting a 4- to 6-fold higher lactic acid production, thus pointing at the potential of microfluidic technology as effective screening tool for fast and parallelizable industrial bioprocess development.
机译:生物过程工程的关键挑战是使用原核以及真核细胞工厂识别生产生化和生物制药化合物的最佳过程条件。摇瓶和台式生物反应器系统仍然是生物过程开发的早期阶段的黄金标准,尽管已知它们是昂贵的,耗时和劳动密集型的昂贵,但缺乏高效生产优化的吞吐量。为了弥合生物过程优化和升级之间的技术差距,我们开发了一种微流体生物反应器阵列,以减少时间和成本,并与传统的实验室规模培养策略相比增加吞吐量。我们介绍了一种多功能的微流体装置,其中包含12个单独的生物反应器(V-T =15μl),在26mm×76mm区域中,具有溶解的氧和生物质浓度的在线生物沉积。在初始设备表征之后,生物反应器实验室芯片用于原则上的验证研究,以鉴定出于两个工程酵母菌株的乳酸产生的最富有成效的细胞系,评估是否可以减少所需的时间与摇瓶文化相比,收集有意义的数据。该研究的结果表明,3小时内的菌株的生产率显着差异,表现出4-6倍的乳酸产生,从而指向微流体技术的潜力,作为快速和平行的工业生物过程开发的有效筛选工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号